Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - pentamidine isetionate -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - ketamine hydrochloride -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - amikacin -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; mannitol - cancer chemotherapeutic drug - details of indications do not appear in the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cisplatin, quantity: 1 mg/ml - injection - excipient ingredients: sodium hydroxide; hydrochloric acid; sodium chloride; mannitol; water for injections - cancer chemotherapeutic drug - details of the indications do not appear on the leaflet as exported from hospira australia

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - carboplatin, quantity: 10 mg/ml - injection - excipient ingredients: water for injections - indications for uk market - treatment of some types of lung cancer and ovarian cancer. indications for france market - it is recommended for the treatment of certain diseases of the ovaries, bronchi and aerodigestive pathways. indications for greece and cyprus market - carboplatin is a second-generation cisplatin derivative which has shown to possess antitumor activity against a number of malignancies. the drug is indicated for the treatment of the following solid tumours: ? ? advanced ovarian carcinoma of epithelial origin. ? ? small cell lung cancer. ? ? non-small cell lung cancer. ? ? epidermoid head and neck cancer. ? ? transitional cell cancer of the bladder (in combination with other cytostatic agents). ? ? cervical carcinoma in case of failure or unacceptable toxicity of cisplatin treatment or when the doctor considers that it cannot be tolerated.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - levetiracetam, quantity: 500 mg - injection, concentrated - excipient ingredients: nitrogen; sodium acetate trihydrate; sodium chloride; glacial acetic acid; water for injections - hospira? levetiracetam concentrate for iv infusion after dilution is an alternative for patients when oral administration is temporarily not feasible. levetiracetam is indicated for: use in epileptic patients aged 4 years and older, initially as add on therapy, in the treatment of partial onset seizures with or without secondary generalisation; monotherapy in the treatment of partial onset seizures, with or without secondary generalisation, in patients from 16 years of age with newly diagnosed epilepsy; add on therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy and add on therapy in the treatment of primary generalized tonic-clonic seizures in adults and children from 4 years of age with idiopathic generalized epilepsy.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - vincristine sulfate, quantity: 1 mg/ml - injection, solution - excipient ingredients: mannitol; water for injections; sulfuric acid; sodium hydroxide - not applicable - to be used as part of the liposome injection kit. details are owned by the licence holder, not hospira.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - atracurium besilate, quantity: 10.5 mg/ml - injection, solution - excipient ingredients: water for injections; benzenesulfonic acid - indications for the united kingdom: atracurium besilate solution for injection is a medicine which acts as a muscle relaxant. atracurium besilate solution for injection is used during surgery to relax muscles and to assist with inserting a breathing tube and with artificial breathing. it is also used to help with artificial breathing in patients in intensive care. indications for france: the injection solution of atracurium is used during surgery to relax the muscles as well as to facilitate the intubation of the endotracheal and assisted ventilation. it is also used to allow artificial ventilation in patients in intensive care.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira pty limited - cefazolin sodium -